The present study investigated the expression of biomarkers TKTL1 and DNaseX/Apo10 in RMS cell lines, in tumor samples as well as in blood samples taken from patients with RMS (using the EDIM blood test). This evidence concerns the gene TKTL1 and neoplasm.